Skip to main content
Top
Published in: Transplant International 1/2004

01-01-2004 | Original Article

Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation

Authors: Delphine Degré, Nadine Bourgeois, Nathalie Boon, Olivier Le Moine, Hubert Louis, Vincent Donckier, Issam El Nakadi, Jean Closset, Pierre Lingier, Pierre Vereerstraeten, Michel Gelin, Michael Adler

Published in: Transplant International | Issue 1/2004

Login to get access

Abstract

Better tools for predicting the risk of death while awaiting transplantation are urgently needed because organ shortage is increasing the numbers on transplantation waiting lists. The aminopyrine breath test (ABT), model for end-stage liver disease (MELD), and Child-Pugh (C-P) score were compared as predictors of this risk in 137 cirrhotic candidates for liver transplantation. Eighty-three were transplanted within 3 months of registration, 35 others survived, 13 died before transplantation, and 6 were removed from the list. By univariate analysis, the continuous variables significantly associated with death while awaiting transplantation were: history of infected ascites, C-P score, ABT, and international normalized ratio or prothrombin time. Receiver operating characteristic curves for quantitative variables showed that the area under the curve was greatest for ABT (0.858±0.067). By Youden curve analysis, the best cut-off points for identifying cirrhotic patients at high risk of death while on the waiting list were: >10, >16, and <0.7% for the C-P score, MELD score, and ABT, respectively. These results show that ABT is as good as the MELD and C-P scores, or better, as a predictor of death among cirrhotic patients awaiting liver transplantation.
Literature
1.
go back to reference Persijn GG, Cohen B, eds. Eurotransplant Annual Report, 2000. Eurotransplant International Foundation: 52. Persijn GG, Cohen B, eds. Eurotransplant Annual Report, 2000. Eurotransplant International Foundation: 52.
2.
go back to reference Harper AM, Edwards EB, Ellison MD. The OPTN waiting list, 1988--2000. Clin Transpl 2001; 73. Harper AM, Edwards EB, Ellison MD. The OPTN waiting list, 1988--2000. Clin Transpl 2001; 73.
3.
go back to reference Wiesner RH. Who and when to list patients for liver transplantation. In: Arroyo V, Bosch Y, Burguera M, Rodés Y, Sanchez Topias YM, eds. Treatment of liver diseases. Barcelona: Masson, 1999:159. Wiesner RH. Who and when to list patients for liver transplantation. In: Arroyo V, Bosch Y, Burguera M, Rodés Y, Sanchez Topias YM, eds. Treatment of liver diseases. Barcelona: Masson, 1999:159.
4.
go back to reference Bronsther O, Fung JJ, Tzakis A, Vanthiel D, Starzl TL. Prioritization and organ distribution for liver transplantation. JAMA 1994; 271:140.CrossRefPubMed Bronsther O, Fung JJ, Tzakis A, Vanthiel D, Starzl TL. Prioritization and organ distribution for liver transplantation. JAMA 1994; 271:140.CrossRefPubMed
5.
go back to reference Everhart JE, Lombardero M, Detre K, et al. Increased waiting time for liver transplantation results in higher mortality. Transplantation 1997; 64:1300.PubMed Everhart JE, Lombardero M, Detre K, et al. Increased waiting time for liver transplantation results in higher mortality. Transplantation 1997; 64:1300.PubMed
6.
go back to reference Davis GL, Albright JE, Cook S. Projecting the future health care burden from hepatitis C in the United States. Hepatology 1998; 28:390A. Davis GL, Albright JE, Cook S. Projecting the future health care burden from hepatitis C in the United States. Hepatology 1998; 28:390A.
7.
go back to reference Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from Child to MELD. Hepatology 2001; 33:473.CrossRefPubMed Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from Child to MELD. Hepatology 2001; 33:473.CrossRefPubMed
8.
go back to reference Suc B, Chalem Y, Golmard JL. Analysis of the French liver transplant waiting list 1992--1996. Transplantation 2000; 69:515.PubMed Suc B, Chalem Y, Golmard JL. Analysis of the French liver transplant waiting list 1992--1996. Transplantation 2000; 69:515.PubMed
9.
go back to reference Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network -- Transplant Data 1990--1999. UNOS, Richmond Va. and the Division of Transplantation, Bureau of Health Resources and Services Administration. US Department of Health and Human Services. Rockville, Md., 2000. Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network -- Transplant Data 1990--1999. UNOS, Richmond Va. and the Division of Transplantation, Bureau of Health Resources and Services Administration. US Department of Health and Human Services. Rockville, Md., 2000.
10.
go back to reference Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464.CrossRefPubMed Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464.CrossRefPubMed
11.
go back to reference Cohen B, ed. Eurotransplant Newsletter, November 2000. Eurotransplant International Foundation: 8. Cohen B, ed. Eurotransplant Newsletter, November 2000. Eurotransplant International Foundation: 8.
12.
go back to reference Hepner GW, Vesell ES. Aminopyrine disposition: studies on breath, saliva and urine in normal subjects and patients with liver disease. Clin Pharmacol Ther 1976; 20:654.PubMed Hepner GW, Vesell ES. Aminopyrine disposition: studies on breath, saliva and urine in normal subjects and patients with liver disease. Clin Pharmacol Ther 1976; 20:654.PubMed
13.
go back to reference Pugh RNH, Murray-Lion IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1979; 60:646. Pugh RNH, Murray-Lion IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1979; 60:646.
14.
go back to reference Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864.PubMed Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864.PubMed
15.
go back to reference Weinstein MC, Fineberg HV. Clinical decision analysis. Philadelphia: Saunders, 1980. Weinstein MC, Fineberg HV. Clinical decision analysis. Philadelphia: Saunders, 1980.
16.
go back to reference Hanley YA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same case. Radiology 1983; 148:839.PubMed Hanley YA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same case. Radiology 1983; 148:839.PubMed
17.
go back to reference Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3:32. Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3:32.
18.
go back to reference Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53:457. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53:457.
19.
go back to reference Gehan EA. A generalized two-sample Wilcoxon test for doubly censored data. Biometrika 1965; 52:203. Gehan EA. A generalized two-sample Wilcoxon test for doubly censored data. Biometrika 1965; 52:203.
20.
go back to reference Schlichting P, Christensen E. Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology 1983; 3:889.PubMed Schlichting P, Christensen E. Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology 1983; 3:889.PubMed
21.
go back to reference Toledo C, Salmeron JM, Rimola A, Navasa M, Arroyo V, Liach J. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection, resolution, and survival in patients treated with cefotoxime. Hepatology 1993; 17:251.PubMed Toledo C, Salmeron JM, Rimola A, Navasa M, Arroyo V, Liach J. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection, resolution, and survival in patients treated with cefotoxime. Hepatology 1993; 17:251.PubMed
22.
go back to reference Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987; 7:660.PubMed Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987; 7:660.PubMed
23.
go back to reference Deschênes M, Villeneuve JP, Dagenais M, et al. Lack of relationship between preoperative measures of the severity of cirrhosis and short-term survival after liver transplantation. Liver Transpl Surg 1997; 3:527. Deschênes M, Villeneuve JP, Dagenais M, et al. Lack of relationship between preoperative measures of the severity of cirrhosis and short-term survival after liver transplantation. Liver Transpl Surg 1997; 3:527.
24.
go back to reference Oellerich M, Burdelski D, Lautz HU, Binder L, Pichlmayr R. Predictors of one year pretransplant survival in patients with cirrhosis. Hepatology 1991; 14:1029.PubMed Oellerich M, Burdelski D, Lautz HU, Binder L, Pichlmayr R. Predictors of one year pretransplant survival in patients with cirrhosis. Hepatology 1991; 14:1029.PubMed
25.
go back to reference Keeffe EB. Summary of guidelines on organ allocation and patient listing for liver transplantation. Liver Transpl Surg 1998; 4: S108.PubMed Keeffe EB. Summary of guidelines on organ allocation and patient listing for liver transplantation. Liver Transpl Surg 1998; 4: S108.PubMed
26.
go back to reference Conn HO. A peek at the Child-Turcotte classification. Hepatology 1981; 1:673.PubMed Conn HO. A peek at the Child-Turcotte classification. Hepatology 1981; 1:673.PubMed
27.
go back to reference Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7:567.CrossRefPubMed Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7:567.CrossRefPubMed
28.
go back to reference Brown RS Jr, Kumar KS, Russo MW, et al. Model for end-stage liver disease and Child--Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002; 8:278.CrossRefPubMed Brown RS Jr, Kumar KS, Russo MW, et al. Model for end-stage liver disease and Child--Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002; 8:278.CrossRefPubMed
29.
go back to reference Christensen E, Schlichting P, Fauerholdt L, et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1984; 4:430.PubMed Christensen E, Schlichting P, Fauerholdt L, et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1984; 4:430.PubMed
30.
go back to reference Sheilman RG, Fulkerson WJ, Delong E, Piantadosi CA. Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit. Crit Care Med 1998; 16:671. Sheilman RG, Fulkerson WJ, Delong E, Piantadosi CA. Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit. Crit Care Med 1998; 16:671.
31.
go back to reference Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology 1996; 24:1392.PubMed Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology 1996; 24:1392.PubMed
32.
go back to reference Llach J, Gines P, Arroyo V, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988; 94:482.PubMed Llach J, Gines P, Arroyo V, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988; 94:482.PubMed
33.
go back to reference Cabre E, Gassull MA. Nutritional support in liver disease. Eur J Gastroenterol Hepatol 1995; 7:528.PubMed Cabre E, Gassull MA. Nutritional support in liver disease. Eur J Gastroenterol Hepatol 1995; 7:528.PubMed
34.
go back to reference Carale JE, McCashland TM, Lyden E, Schafer DF, Sorrell MF, Langnas A. MELD scoring system is not predictive of mortality in patients waiting for liver transplantation (abstract). Gastroenterology 2001: A69. Carale JE, McCashland TM, Lyden E, Schafer DF, Sorrell MF, Langnas A. MELD scoring system is not predictive of mortality in patients waiting for liver transplantation (abstract). Gastroenterology 2001: A69.
36.
go back to reference Beuers U, Jäger F, Wahländer A, Ansari H, Kirsh CM. Prognostic value of the intravenous14C-aminopyrine breath test compared to the Child-Pugh score and serum bile acids in 84 cirrhotic patients. Digestion 1991; 50:212.PubMed Beuers U, Jäger F, Wahländer A, Ansari H, Kirsh CM. Prognostic value of the intravenous14C-aminopyrine breath test compared to the Child-Pugh score and serum bile acids in 84 cirrhotic patients. Digestion 1991; 50:212.PubMed
37.
go back to reference Merkel C, Bolognesis M, Bellon S, et al. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut 1992; 33:836.PubMed Merkel C, Bolognesis M, Bellon S, et al. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut 1992; 33:836.PubMed
38.
go back to reference Urbain D, Muls V, Thys O, Ham R. Aminopyrine breath test improves long-term prognostic evaluation in patients with alcoholic cirrhosis in Child classes A and B. J Hepatol 1995; 22:179.CrossRefPubMed Urbain D, Muls V, Thys O, Ham R. Aminopyrine breath test improves long-term prognostic evaluation in patients with alcoholic cirrhosis in Child classes A and B. J Hepatol 1995; 22:179.CrossRefPubMed
39.
go back to reference Adler M, Van Laethem JL, Gilbert A, et al. Factors influencing survival at one year in patients with non-biliary hepatic cirrhosis. Dig Dis Sci 1990; 35:1.PubMed Adler M, Van Laethem JL, Gilbert A, et al. Factors influencing survival at one year in patients with non-biliary hepatic cirrhosis. Dig Dis Sci 1990; 35:1.PubMed
Metadata
Title
Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation
Authors
Delphine Degré
Nadine Bourgeois
Nathalie Boon
Olivier Le Moine
Hubert Louis
Vincent Donckier
Issam El Nakadi
Jean Closset
Pierre Lingier
Pierre Vereerstraeten
Michel Gelin
Michael Adler
Publication date
01-01-2004
Publisher
Springer-Verlag
Published in
Transplant International / Issue 1/2004
Print ISSN: 0934-0874
Electronic ISSN: 1432-2277
DOI
https://doi.org/10.1007/s00147-003-0655-6

Other articles of this Issue 1/2004

Transplant International 1/2004 Go to the issue